Leading Long COVID scientists, government officials, and advocates are meeting today and tomorrow in Bethesda, Maryland for the third annual RECOVER-Treating Long COVID (TLC) workshop, hosted by the ...

Together, they carry grief, sex, stigma, government abandonment, and the intimate devastation of lovers disappearing faster ...

Multiple COVID-19 precautions during the Tokyo Olympic and Paralympic Games were effective in minimizing SARS-CoV-2 transmission, according to a new study in Eurosurveillance. Using retrospective ...

Higher COVID-19 levels from the summer’s surge are still persisting through late October. Some regions where we thought the ...

For those who can work at all — around 8 in 10, one study found — accommodations are often what makes it possible. The costs ...

Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.

Here are the latest national COVID-19 trends, according to the U.S. Centers for Disease Control and Prevention (CDC) and major wastewater surveillance providers: This summer’s COVID-19 wave is still ...

Leading Long COVID scientists, government officials, and advocates are meeting today and tomorrow in Bethesda, Maryland for the third annual RECOVER-Treating Long COVID (TLC) workshop, hosted by the ...

This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease levels in mid-October. While there’s some conflicting data about where ...

While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. The novel drug ...